Quantum Farma is rebranding as Quantum Life Sciences. This rebranding has been necessary due to our expansion into biomedical technologies, nutraceuticals, cosmeceuticals, food processing, and other fields dedicating our efforts to create products and services to improve the lives of humans and animals.
Quantum Life Sciences is committed to expanding access to cannabinoid medicines worldwide through evidence-based research and quality approved products.
Learn more about our continuing expansion and business opportunities throughout Latin America and Europe.
Established partnerships with pharma and industrial companies globally
Distribution partners for GMP grade cannabinoid containing products throughout Latin America & Europe
Evidence-based human and animal health with phyto-cannabinoids
25+ years of financial markets experience, primarily within LATAM & Emerging Markets. Head of LATAM at Nomura Securities, Barclays and Head of Global Markets for LATAM at Deutsche Bank overseeing strategic expansion of Latin America leading to record revenues and top league table positions.
20+ years of experience as a primary care physician and cannabis specialist at Massachusetts General Hospital and an Instructor in Medicine at Harvard Medical School. He is a certified Health and Wellness Coach as well as a board member of the advocacy group Doctors for Cannabis Regulation. Dr. Grinspoon is a widely recognized expert on cannabis science and drug policy.
30+ years of scientific and commercial pharmaceutical experience in the UK and globally. Previously the Scientific Lead at GW Pharma for 9 years working on R&D of the Sativex & Epidiolex products while also developing their commercial strategy
30+ years operational, advisory & consulting experience across a multitude of sectors (FMCG, hospitality, media & entertainment, manufacturing) in companies like EY, HMV/EMI, HAYS, Unilever in the UK, sub-Saharan Africa, the Middle East and India. ‘Go to market’ strategy advisor to start-ups and medium sized consumer facing businesses.